M&A Deal Summary |
|
---|---|
Date | 2009-03-16 |
Target | Innovatis AG |
Sector | Life Science |
Buyer(s) | Roche |
Sellers(s) | VM Capital |
Deal Type | Add-on Acquisition |
Deal Value | 15M EUR |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1896 |
Sector | Life Science |
Employees | 100,920 |
Revenue | 60.4B CHF (2023) |
Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.
DEAL STATS | # |
---|---|
Overall | 11 of 42 |
Sector (Life Science) | 8 of 29 |
Type (Add-on Acquisition) | 9 of 35 |
Country (Germany) | 1 of 4 |
Year (2009) | 2 of 2 |
Size (of disclosed) | 27 of 29 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-03-12 |
Genentech
San Francisco, California, United States Genentech is a biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The Company is based in San Francisco. |
Buy | $46.8B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-03-15 |
PVT Probenverteiltechnik
Waiblingen, Germany PVT Probenverteiltechnik GmbH providing customised automation and workflow solutions for in-vitro diagnostic (IVD) testing in large commercial and hospital laboratories. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2000 |
PE ASSETS | 675M EUR |
Size | Middle-Market |
Type | Sector Agnostic |
VM Capital (formerly known as Ventizz Capital Partners) is a private equity firm that targets investments in growth-oriented technology businesses operating throughout Europe. VM Capital will consider investing in individual companies as well as acquisitions of secondary private equity transactions. Specific sectors of interest include renewable energy/clean technology, semiconductors, electronics, photonics, materials applicaton, industrial automation, medical technology, IT, and communications. Vorndran looks for control stakes when making investments. The Firm's investment horizon is 3 to 6 years. VM Capital was formed in 2000 and is based in Dusseldorf.
DEAL STATS | # |
---|---|
Overall | 8 of 19 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 2 of 6 |
Country (Germany) | 6 of 13 |
Year (2009) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-01-22 |
Visioncard
Kematen, Austria Visioncard Kunststoffkarten-Produktions GmbH, based in Kematen/Austria, specializes in producing and printing chipcards and plastic cards. Visioncard is geared to larger volumes and has market-leading competence in all of the standard printing methods (offset, screen, thermal sublimation and thermal transfer printing). |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-10-01 |
Medi-Globe
Stuttgart, Germany Medi-Globe is a developer, producer, and distributor of medical instruments, catheters, implants, and wound care, focusing on minimal-invasive and non-invasive endoscopy applications. Medi-Globe was founded in 1985 and is based in Stuttgart, Germany. |
Sell | - |